Manuel Serrano

Manuel Serrano discovered p16INK4a as a critical tumor suppressor and has pioneered in vivo cellular reprogramming approaches that reverse senescence while maintaining tumor suppression. His work demonstrates that transient expression of Yamanaka factors can rejuvenate senescent tissues and reduce cancer susceptibility without inducing teratomas. He develops next-generation senolytic strategies based on partial reprogramming for clinical cancer prevention.